Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by biorunon Nov 19, 2022 12:40am
194 Views
Post# 35112240

RE:Bio - run, where is that rally you were speaking about?

RE:Bio - run, where is that rally you were speaking about?The rally this week? yeah, earlier I was talking about my bold prediction we would see something over the next 4-5 months with momentum around anti-aging, anti-viral and pets.  There was a lot more shares than average traded this week on the heels of the announcement that the anti-aging trial is about to start - there is interest but you are right, the day was dry.

Yes, two points of reference this week (news plus the Abbvie reference) are certainly helpful - and looks as if it provoked a reversal but if bullish orientation of trading history for me dictates, the next supercycle is damn real possibility. If they can pick up some cash from a deal or even scientific collaboration then that significantly derisks the financial question and lays the runway to bridge to royalties profitability and we would be off to the races. if not we inch up on milder but meaningful non revenue business developments.

it all depends upon what they come up with.

<< Previous
Bullboard Posts
Next >>